Teladoc Health, Inc. (TDOC)

CIK 0001477449 · Healthcare · Health Information Services

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-29) · 99.1
Q1-2026 8-K (2026-04-29) · 99.1
Latest FY-2025 8-K (2026-02-25) · 99.1
Q3-2025 8-K (2025-10-29) · 99.1  |  8-K (2025-10-23) · 99.1
Q2-2025 8-K (2025-07-29) · 99.1
Q1-2025 8-K (2025-04-30) · 99.1
FY-2024 8-K (2025-02-26) · 99.1
Q3-2024 8-K (2024-10-30) · 99.1
Q2-2024 8-K (2024-07-31) · 99.1
Q1-2024 8-K (2024-04-25) · 99.1  |  8-K (2024-04-05) · 99.1
FY-2023 8-K (2024-02-20) · 99.1
Q3-2023 8-K (2023-10-24) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Operations and Other Comprehensive Loss
—
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders' Equity (P)
—
Notes
401(k) Plan
—
Accrued Expenses and Other Current Liabilities
Acquisitions
Basis of Presentation and Principles of Consolidation
—
Commitments and Contingencies
Common Stock and Stockholders' Equity
Convertible Senior Notes
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Fair Value Measurements
—
Goodwill
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Assets, Net and Certain Cloud Computing Costs
Inventories
Leases
Legal Matters
—
Net Loss Per Share
—
Organization and Description of Business
Pay Vs Performance Disclosure
Prepaid Expenses and Other Current Assets
Property and Equipment, Net
—
Provision For Income Taxes
—
Restructuring
Revenue, Deferred Revenue, and Deferred Costs and Other
—
Revenue, Deferred Revenue, and Deferred Device and Contract Costs
Schedule Ii
—
Segments
Stock-based Compensation
—
Subsequent Events
Summary of Significant Accounting Policies
—